General : CRM Strengthens Malaysia's Clinical Trial Ecosystem, AstraZeneca Supports Research Investment

KUALA LUMPUR, May 5 (Bernama) -- Clinical Research Malaysia (CRM) will continue to play a critical role in ensuring Malaysia becomes a leading destination for clinical trials by working closely with regulators, hospitals, academia, and industry partners to improve trial readiness and delivery.

Go to News Site